RICE HALL JAMES & ASSOCIATES, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$368,000
-66.5%
513,292
+5.6%
0.02%
-61.5%
Q4 2021$1,099,000
-32.6%
486,220
-14.1%
0.04%
-35.0%
Q3 2021$1,630,000
-22.2%
566,026
+2.4%
0.06%
-20.0%
Q2 2021$2,096,000
+7.2%
552,976
-4.3%
0.08%
+17.2%
Q1 2021$1,956,000
-54.8%
577,972
-62.6%
0.06%
-57.9%
Q4 2020$4,329,000
+9.2%
1,546,169
-2.1%
0.15%
-5.0%
Q3 2020$3,963,000
-78.7%
1,579,079
+15.0%
0.16%
-80.0%
Q2 2020$18,644,000
+74.8%
1,372,888
-2.4%
0.80%
+34.2%
Q1 2020$10,666,000
+20.7%
1,407,164
+0.6%
0.60%
+99.3%
Q4 2019$8,839,000
+51.9%
1,398,621
-5.8%
0.30%
+43.8%
Q3 2019$5,818,000
-19.5%
1,484,137
-0.7%
0.21%
-13.3%
Q2 2019$7,231,000
-42.9%
1,494,070
-3.3%
0.24%
-41.2%
Q1 2019$12,659,000
+87.4%
1,545,682
+26.5%
0.41%
+65.9%
Q4 2018$6,755,000
+1802.8%
1,221,498
+2937.0%
0.25%
+1792.3%
Q3 2018$355,00040,2200.01%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders